(Q41112347)

English

Inhibition of coxsackievirus B3 carrier state infection of cultured human myocardial fibroblasts by ribavirin and human natural interferon-alpha

scientific article published on May 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 September 2017

Inhibition of coxsackievirus B3 carrier state infection of cultured human myocardial fibroblasts by ribavirin and human natural interferon-alpha (English)

1 reference

Europe PubMed Central

26 September 2017

0 references

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

26 September 2017

author name string

Grumbach I

2

1 reference

Europe PubMed Central

26 September 2017

Pring-Akerblom P

3

1 reference

Europe PubMed Central

26 September 2017

Stille-Siegener M

4

1 reference

Europe PubMed Central

26 September 2017

Müller G

5

1 reference

Europe PubMed Central

26 September 2017

Kandolf R

6

1 reference

Europe PubMed Central

26 September 2017

Figulla HR

7

1 reference

Europe PubMed Central

26 September 2017

publication date

1 May 1997

1 reference

Europe PubMed Central

26 September 2017

Antiviral Research

1 reference

Europe PubMed Central

26 September 2017

34

1 reference

Europe PubMed Central

26 September 2017

3

1 reference

Europe PubMed Central

26 September 2017

101-111

1 reference

Europe PubMed Central

26 September 2017

Viral Myocarditis and its Sequelae

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The interferons: a biological system with therapeutic potential in viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple drug effect analysis with confidence interval

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacology and side-effects of interferons.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of coronary angiography, left heart catheterization, and endomyocardial biopsy for the diagnosis of idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Myocardial enterovirus infection with left ventricular dysfunction: a benign disease compared with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemistry and clinical applications of ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergistic interaction of interferon-beta and interferon-gamma in coxsackievirus B3-infected carrier cultures of human myocardial fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cultured human myocardial fibroblasts of pediatric origin: natural human interferon-alpha is more effective than recombinant interferon-alpha 2a in carrier-state coxsackievirus B3 replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant Interferons beta and gamma have a higher antiviral activity than interferon-alpha in coxsackievirus B3-infected carrier state cultures of human myocardial fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribavirin treatment of murine coxsackievirus B3 myocarditis with analyses of lymphocyte subsets.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Genomic detection of enteroviruses in the myocardium--studies on animal hearts with coxsackievirus B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ribavirin on intrahepatic and extrahepatic expression of hepatitis C virus in interferon nonresponsive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Recently diagnosed idiopathic dilated cardiomyopathy: incidence of myocarditis and efficacy of prednisone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and long-term tolerance to ribavirin in asymptomatic patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon and thymic hormones in the therapy of human myocarditis and idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse effects and drug interactions of clinical importance with antiviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative pharmacokinetics of antiviral nucleoside analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular mechanisms of action of ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribavirin treatment for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribavirin: An antiviral agent

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribavirin cures cells of a persistent infection with foot-and-mouth disease virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical Pharmacokinetics of Interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901028-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0166-3542(97)01028-0

1 reference

Europe PubMed Central

26 September 2017

1 reference

Europe PubMed Central

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41112347&oldid=2094038213"